AB Science (France) Investor Sentiment

AB Stock  EUR 0.82  0.04  5.13%   
About 55% of AB Science's investors are presently thinking to get in. The analysis of current outlook of investing in AB Science SA suggests that some traders are interested regarding AB Science's prospects. The current market sentiment, together with AB Science's historical and current headlines, can help investors time the market. In addition, many technical investors use AB Science SA stock news signals to limit their universe of possible portfolio assets.
  
over a month ago at news.google.com         
AB Science announces a slight delay in the publication of its 2024 half-year financial report - Yaho...
Google News at Macroaxis
over two months ago at news.google.com         
AB Science provides an update on the microtubule program AB89 and in particular the ability of AB89 ...
Google News at Macroaxis
over two months ago at news.google.com         
AB Science provides an update on the development of masitinib in progressive forms of multiple scler...
Google News at Macroaxis
over three months ago at news.google.com         
Allstate Sets New 12-Month High on Analyst Upgrade - Defense World
Google News at Macroaxis
over three months ago at news.google.com         
Integral Ad Science Holding Corp. CFO Sells 44,179.52 in Stock - American Banking and Market News
Google News at Macroaxis
over three months ago at news.google.com         
AB Science announces positive results of its Phase 2 study evaluating masitinib in Covid-19 - Yahoo ...
Google News at Macroaxis
over three months ago at news.google.com         
Lilly follows Biogen-Eisai in securing US FDA approval for Alzheimers drug - Reuters
Google News at Macroaxis
over three months ago at news.google.com         
EMA takes negative view on masitinib Ocaliva, Translarna out - BioWorld Online
Google News at Macroaxis
over three months ago at news.google.com         
Air Canada Short Interest Up 20.1 percent in June - Defense World
Google News at Macroaxis
over three months ago at news.google.com         
MicroSectors U.S. Big Oil Index 3x Leveraged ETN Shares Gap Up to 492.88 - Defense World
Google News at Macroaxis
over three months ago at news.google.com         
Park Avenue Securities LLC Sells 1825 Shares of iShares Russell 2000 Value ETF - Defense World
Google News at Macroaxis
over three months ago at news.google.com         
AB Science EPAAB investor three-year losses grow to 85 percent as the stock sheds 8.3m this past wee...
Google News at Macroaxis
over six months ago at news.google.com         
AB Science is providing a summary of the live webcast held on May 30, 2024, giving an update on the ...
Google News at Macroaxis
over six months ago at news.google.com         
AB Science reports its revenues for the year 2023 and provides an update on its activities - GlobeNe...
Google News at Macroaxis
over six months ago at news.google.com         
AB Science announces issuance of a European patent for masitinib in the treatment of severe mastocyt...
Google News at Macroaxis
Far too much social signal, news, headlines, and media speculation about AB Science that are available to investors today. That information is available publicly through AB Science media outlets and privately through word of mouth or via AB Science internal channels. However, regardless of the origin, that massive amount of AB Science data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of AB Science news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of AB Science relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to AB Science's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive AB Science alpha.

AB Science Performance against Dow Jones

 Price Growth (%)  
       Timeline  

Complementary Tools for AB Science Stock analysis

When running AB Science's price analysis, check to measure AB Science's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AB Science is operating at the current time. Most of AB Science's value examination focuses on studying past and present price action to predict the probability of AB Science's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AB Science's price. Additionally, you may evaluate how the addition of AB Science to your portfolios can decrease your overall portfolio volatility.
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Equity Valuation
Check real value of public entities based on technical and fundamental data
Bonds Directory
Find actively traded corporate debentures issued by US companies
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Share Portfolio
Track or share privately all of your investments from the convenience of any device
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope